Interference of Daratumumab Treatment in the Biological Monitoring of Multiple Myeloma

Key Points

• This research aims to identify how daratumumab interferes with the biological monitoring of multiple myeloma.
• Analyzed biological samples from multiple myeloma patients undergoing daratumumab treatment.
• Emphasized the necessity of collaboration between clinicians and biologists for interpreting results.
• Daratumumab causes significant interference in biological assays used for monitoring multiple myeloma.
• Accurate interpretation of treatment responses requires enhanced communication between clinicians and biologists.